It suggests that RegCs in tumor may induce tumor progression by promoting cell adhesion and the secretion of proteoglycan between tumor cells, but also indicates RegCs adjacent to cancer tissues may activate TGF-beta, p53, and other pathways to promote apoptosis and inhibit tumor development. This evidence concerns the gene TP53 and neoplasm.